Short answer
PHIBRO ANIMAL HEALTH CORP (PAHC) filed its Q3 2025 10-Q quarterly report on Nov 5, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $364M (up 39.7% year over year) with net income of $27M.
Q3 2025 key financials · XBRL
- Revenue
- $364M
- +39.7% YoY
- Net income
- $27M
- +280.3% YoY
- Operating margin
- 14.1%
- Gross margin
- 32.9%
- EPS (diluted)
- $0.65
- +282.4% YoY
Source: XBRL data from the PHIBRO ANIMAL HEALTH CORP (PAHC) Q3 2025 10-Q on SEC EDGAR. USD.
PHIBRO ANIMAL HEALTH CORP Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $363.9M, up 40% YoY from $260.4M
- Operating margin 14.1% vs 6.8%; gross margin 32.9% vs 32.1%
- Best segment Animal Health revenue $283.5M, up 55%; MFAs and other up 81% to $195.2M
- Worst segment Performance Products revenue $17.4M, down 7%; adjusted EBITDA margin 9.2% vs 12.1%
- Operating cash flow $9.3M vs $12.6M; capital expenditures $13.8M and dividends $4.9M
- Outlook supported by cash, operating flows and credit availability; headwinds include tariffs, conflicts, supply disruptions and carbadox regulatory risk
Risk Factors
- No material changes to risk factors from the Annual Report
- No newly added risk factor identified for fiscal 2025
- No updated regulatory, legal, compliance, operational, competitive, or financial risk disclosed
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other PHIBRO ANIMAL HEALTH CORP quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.